The 20 Best Neuronal Intranuclear Inclusion Disease (NIID) Doctors Near Me in Ann Arbor, MI

Judith Heidebrink is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Heidebrink is rated as a Distinguished provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Alzheimer's Disease, Cerebellar Degeneration, Lewy Body Dementia (LBD), and Dementia.

Rachel Denny is a primary care provider, practicing in Internal Medicine and Geriatrics in Ann Arbor, Michigan. Dr. Denny is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). Her clinical expertise encompasses Delirium, Lewy Body Dementia (LBD), Neuronal Intranuclear Inclusion Disease (NIID), and Heart Failure. Dr. Denny is board certified in Family Medicine and Geriatric Medicine.

Kirk Frey is a Neurologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Frey is rated as an Advanced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Neuroendocrine Tumor, Osteopenia, and Hormone Replacement Therapy (HRT).

Navid Seraji-Bozorgzad, MD, is an associate professor of neurology in the University of Michigan Medical School.Dr. Seraji-Bozorgzad began work in the area of medical imaging in 1990 as a research assistant during his undergraduate studies at the University of Michigan. He became familiar and developed a fundamental understanding of image acquisition and processing from his work on solid-state imaging arrays. After undergraduate work, he worked in the private sector as a software engineer, designing databases for various companies, including Ford Motor Company, and Liberty Mutual Insurance. The work provided him with experience in data-mining and manipulation of large datasets.His passion for medicine eventually led him to medical school. During the application process he worked in the Department of Psychiatry and Behavioral Neurosciences, and eventually enrolled in graduate school in neuroscience. While in the Department of Psychiatry, he participated in the use of various MR imaging techniques, including magnetic resonance spectroscopy and functional MRI for diagnosis and disease progression in mood disorders, including bipolar disorder. It was during his graduate studies that he developed an interest in the field of neurodegeneration, regeneration and neuroprotection.Dr. Seraji-Bozorgzad's research interest is primarily with non-invasive methods of monitoring disease progression in neurodegenerative disorders, with the ultimate goal of developing a tool set to monitor the efficacy of therapies early on in neurodegenerative disorders.His bibliography includes numerous peer-reviewed jornals and publications, abstracts and other media. Dr. Seraji is rated as an Advanced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cerebellar Degeneration, Dementia, Vascular Dementia, and Alzheimer's Disease.

Sami Barmada, M.D., Ph.D. is an assistant professor of neurology at the University of Michigan Medical School. His clinical interests center around patients with dementia and motor neuron disease, and he sees patients at the Cognitive Disorders Clinic in the University of Michigan’s East Ann Arbor location.His research focuses on the pathologic overlap between amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), and how we can take advantage of the convergence to identify new and effective therapies for these devastating disorders.After graduating from the University of Pittsburgh, Pennsylvania, in 1998 with a major in Molecular Biology, Biochemistry, and a focus in Conceptual Foundations of Medicine, Dr. Barmada went on to the Medical Scientist Training Program at Washington University in St. Louis School of Medicine. For his graduate work, he constructed a transgenic mouse model of Creutzfeldt-Jacob disease with Dr. David Harris, and used these animals to track the deposition of misfolded prion protein within the nervous system of infected animals. For this work, Dr. Barmada earned earned the Poletsky Award from the Alzheimer’s Disease Research Center in St. Louis, Missouri, and was elected as a Olin Medical Scientist Fellow at Washington University School of Medicine.Dr. Barmada received his M.D. and Ph.D. in 2006, and completed an Internal Medicine internship at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri, before moving to the University of California, San Francisco (UCSF), Medical Center for his residency in Neurology. Dr. Barmada served one year as Chief Resident in the Department of Neurology, focusing on resident education. He was also a house-staff nominee to the Alpha-Omega-Alpha honor society. During his residency, Dr. Barmada became involved in research with Dr. Steve Finkbeiner of the Gladstone Institutes, a pioneer in neuronal models of neurodegenerative disease and novel technologies to study these models. Dr. Barmada finished his residency in 2010 and spent one year working with Dr. Finkbeiner as a research fellow, before becoming a Staff Scientist at the Gladstone Institutes and a Clinical Instructor at UCSF. In 2013, Dr. Barmada became an Assistant Professor of Neurology at the University of Michigan, where he divides his time between the Cognitive Disorders Clinic and the laboratory. Dr. Barmada is rated as an Advanced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Frontotemporal Dementia, and Dementia. Dr. Barmada is board certified in Neurology.

Roger L. Albin, M.D. (Residency 1986), is a professor of neurology, associate chair for research and co-director of the Movement Disorders Clinic in the Department of Neurology in the University of Michigan Medical School. In addition, he serves as chief of neuroscience research at the VA Ann Arbor Healthcare System Geriatric Research Education and Clinical Center.Dr. Albin joined the U-M faculty in 1988 as an instructor in the Department of Neurology. He was promoted to assistant professor in 1989; associate professor in 1994; and achieved his current rank of full professor in 2000.After completing his undergraduate degree at Oberlin College in Ohio, Dr. Albin earned his medical degree from the University of Pittsburgh School of Medicine in 1982, and completed his residency at the University of Michigan in 1986. He also completed a movement disorders fellowship in 1988 under Drs. Anne Young and John Penney.His clinical and research interests include the underlying neurobiologic causes of the clinical features of movement disorders, basal ganglia structure and function, Parkinson's disease, Tourette syndrome, dementias, dystonias and Huntington's disease. His laboratory is pursuing work on basic mechanisms of neurodegeneration in Huntington disease using mouse genetic models. Dr. Albin also has participated in neuroprotective clinical trials for both Huntington's disease and Parkinson's disease.The present focus of Dr. Albin's group is uncovering the basis for non-motor (sleep disorders, depression, dementia, autonomic dysfunction) problems in Parkinson's disease. He is very interested in applying positron emission tomography (PET) imaging methods to improve diagnosis of dementing disorders like Alzheimer's disease. The hope is that understanding how specific brain alterations cause specific clinical features will lead to improved treatments.Dr. Albin currently serves as a site investigator for the National Institutes of Health (NIH) Exploratory Trials in Parkinson disease (NET-PD) initiative. His work is supported by grants from the NIH, the Michael J. Fox Foundation and the High Q Foundation.A member of the American Academy of Neurology, the American Association for the Advancement of Science, the American Neurologic Association, and the Society for Neuroscience, Dr. Albin currently serves on the editorial boards of Experimental Neurology, Neurology and Neurobiology of Disease. Dr. Albin is rated as an Advanced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Huntington Disease, Dementia, and Deep Brain Stimulation. Dr. Albin is board certified in Neurology.

Henry L. Paulson, M.D., Ph.D., is the Lucile Groff Professor of Neurology for Alzheimer's Disease and Related Disorders in the Department of Neurology at the University of Michigan. Dr. Paulson joined the U-M faculty in 2007, and he currently directs the Michigan Alzheimer’s Disease Center (MADC) and co-direct the U-M Protein Folding Diseases Initiative.Dr. Paulson received his medical degree and doctorate in Cell Biology from Yale University in 1990. He then completed a neurology residency and neurogenetics/movement disorders fellowships at the University of Pennsylvania. In 1997, he joined the Neurology faculty at the University of Iowa, where he remained until 2007.Dr. Paulson's research and clinical interests concern the causes and treatment of age-related neurodegenerative diseases, with an emphasis on polyglutamine diseases, Alzheimer's disease and frontotemporal dementia. In 1997, his lab described abnormal protein aggregates in the polyglutamine diseases, which now are recognized as a pathological hallmark in this important class of inherited diseases. Using test tube, cell-based and animal models, he has contributed to advances in the understanding of various neurodegenerative diseases. His lab also has helped pioneer the use of gene silencing methods as potential therapy for the many neurological disorders caused by toxic mutant genes.Nationally, Dr. Paulson has directed popular courses at the American Academy of Neurology meetings, serves on the scientific advisory boards of numerous disease-related national organizations, and is past Chair of the Board of Scientific Counselors at the National Institute for Neurological Disorders and Stroke at the National Institutes of Health.Among his awards, Dr. Paulson is an Ellison Medical Foundation New Scholar in Aging, a semifinalist for the W.M. Keck Foundation Young Scholars in Medical Research, and a recipient of the Paul Beeson Physician Faculty Scholar in Aging Award from the American Federation for Aging Research. Dr. Paulson is rated as an Advanced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia Type 3, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, and Drug Induced Dyskinesia. Dr. Paulson is board certified in Neurology.

Stephen Goutman, MD, MS is an Associate Professor in the Department of Neurology and Director of the Amyotrophic Lateral Sclerosis Clinic and ALS Center of Excellence at Michigan Medicine. After obtaining a degree in neuroscience at the Johns Hopkins University (Baltimore, MD), Dr. Goutman completed his medical degree at the University of Chicago Pritzker School of Medicine (Chicago, IL) and his neurology residency and neuromuscular fellowship at Cleveland Clinic (Cleveland, OH). He received a Master’s in Clinical Research Design and Statistical Analysis at the University of Michigan (Ann Arbor, MI).Dr. Goutman evaluates and treats patients with neuromuscular diseases and is interested in diseases such as myasthenia gravis and muscle diseases. His area of expertise is amyotrophic lateral sclerosis (ALS)/Lou Gehrig’s Disease where his focus is delivering comprehensive and compassionate care. He is Director of the ALS Clinic, an ALS Association Certified Center of Excellence (http://www.umich-als.org/), where he leads a team of providers that care for persons with ALS and their families. Dr. Goutman is inspired by his patients and thus aims to provide the highest level of care.Dr. Goutman’s research is focused on identifying causes of and treatments for ALS. He leads research efforts that received funding by the National Institutes of Health and the Centers for Disease Control aimed at identifying environmental risk factors and causes of ALS (https://umhealthresearch.org/#studies/HUM00028826) and showed, in an article that received widespread attention, a connection between ALS and organochlorine pesticides (https://jamanetwork.com/journals/jamaneurology/fullarticle/2519875). Dr. Goutman also helps direct the University of Michigan ALS Biorepository which provides essential resources to ALS researchers within and external to the University of Michigan enabling studies into areas of ALS genetics, epigenetics, and immunology.Dr. Goutman is a site principal investigator of several multisite clinical trials focused on identifying new ALS treatments and causes and is an active participant with the Northeast ALS Consortium (NEALS) to improve care for ALS. He received a 2016 Young Investigator Award by the World Federation of Neurology Research Group on Motor Neuron Diseases. Dr. Goutman is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), and Spinal and Bulbar Muscular Atrophy. Dr. Goutman is board certified in Neurology, Neuromuscular Medicine, and Electrodiagnostic Medicine.

Peter Kelterborn is a primary care provider, practicing in Internal Medicine in Ann Arbor, Michigan. Dr. Kelterborn is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Vertigo, and Dementia. Dr. Kelterborn is board certified in Internal Medicine.

Susan Maixner is a Palliative Medicine specialist and a Psychiatrist practicing medicine in Ann Arbor, Michigan. Dr. Maixner is rated as an Advanced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Bipolar Disorder (BPD), Major Depression, Seasonal Affective Disorder (SAD), and Lewy Body Dementia (LBD). Dr. Maixner is board certified in Hospice & Palliative Med, Psychiatry, and Geriatric Psychiatry.

Heba Gad is a Psychiatrist and a Geriatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Gad is rated as an Advanced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Major Depression, Seasonal Affective Disorder (SAD), Bipolar Disorder (BPD), and Vascular Dementia. Dr. Gad is board certified in Psychiatry and Geriatric Psychiatry.

Dr. MacDonald grew up in St. Ignace, a small town in Michigan’s Upper Peninsula. He attended medical school at Michigan State University’s College of Human Medicine. From there, he completed his neurology residency and then a fellowship in Behavioral Neurology at the Cleveland Clinic.Dr. MacDonald’s primary interests are related to the diagnosis and management of different neurodegenerative diseases of the brain such as Alzheimer’s disease, Lewy body disease, vascular dementia, and frontotemporal dementia. In addition to his clinical activities, Dr. MacDonald has also participated in several clinical trials assessing the safety and efficacy of drugs designed to slow the progression of certain neurodegenerative disorders. Dr. Macdonald is rated as an Advanced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Cerebellar Degeneration, Dementia, Charles Bonnet Syndrome, Primary Progressive Aphasia, and Hip Replacement. Dr. Macdonald is board certified in Neurology.

Mary Blazek is a Psychiatrist and a Geriatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Blazek is rated as an Advanced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Major Depression, Seasonal Affective Disorder (SAD), Vascular Dementia, and Lewy Body Dementia (LBD).

Tanav Popli is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Popli is rated as an Advanced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Frontotemporal Dementia, Primary Progressive Aphasia, Neuronal Intranuclear Inclusion Disease (NIID), and Dementia. Dr. Popli is board certified in Neurology.

Dr. Almeda received her medical degree from Michigan State University College of Osteopathic Medicine in East Lansing, Michigan in 1998. She completed her Internal Medicine residency at McLaren Macomb Hospital in Mount Clemens, Michigan and then her Geriatrics fellowship at the University of Michigan in Ann Arbor in 2002. She is board certified in Geriatrics and is a Fellow in the American College of Osteopathic Internists. After spending 12 years as a house call physician serving frail, homebound, older adults, she rejoined her alma mater in 2014 as a Clinical Instructor in the Division of Geriatrics at the University of Michigan, where she helps educate medical students, Internal Medicine residents, and Geriatric and Palliative Care Fellows in the outpatient setting. In April 2020 she was named Medical Director at Huron Valley PACE, a comprehensive program in Ypsilanti that helps nursing home eligible older adults remain in their homes until the end of their life. Dr. Almeda is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Colitis, Lewy Body Dementia (LBD), Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Almeda is board certified in Geriatric Medicine.

Dr. Dewar received her medical degree from The Tamilnadu Dr. MGR Medical University, Chennai, India. She completed a family medicine residency at University of Connecticut and geriatric fellowship at the University of Michigan. She is board-certified in obesity medicine, geriatric medicine, and family medicine. Dr. Dewar speaks English and Tamil. Her special clinical interests include geriatrics and obesity. She is the founder and director of the Optimal Health Weight and lifestyle clinic (OHWL), a weight management clinic for older adults in East Ann Arbor Geriatrics Center. Dr. Dewar is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). Her clinical expertise encompasses Dementia, High Potassium Level, Urinary Tract Infection (UTI), and Decerebrate Posture.

Dr. Wiggins joined the U-M geriatrics department in 1995. She is the Medical Director for the Geriatric Inpatient Consult Team and the former Medical Director for the Geriatrics Center Clinics from 2005-2019. She oversaw the relocation of the clinic from the main medical campus to its current location in the East Ann Arbor Health and Geriatrics Center. She previously co-chaired the geriatric advisory group for the American Society of Nephrology and oversaw the development of a geriatric nephrology curriculum to improve the care of older patients with kidney disease. She served on the external advisory committee for the association of subspecialty professors, T. Franklin Williams Scholars Program, to promote improved care for the elderly across the medical subspecialties. She is the current President for the Internal Medicine Clinical Excellence Society(CES), and former Chair of the CES Women’s Sub-Committee. Dr. Wiggins’ research and publications focus on aging in the kidney, and she reviews for several scientific journals. Dr. Wiggins is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Delirium, Lewy Body Dementia (LBD), Focal Segmental Glomerulosclerosis, and Cerebellar Degeneration.

"Dr. Gargi Vidholia is a Geriatrician who earned her MBBS at Delhi University's College of Medical Sciences and advanced her training in the U.S., completing her Family Medicine residency at the North Oakland Medical Center in Pontiac and a Geriatric Medicine Fellowship at the Cleveland Clinic Foundation in Ohio. She is board certified in Family Medicine and holds a Certificate of Added Qualification in Geriatric Medicine.Dr. Vidholia has been a Senior Staff Physician at the Henry Ford Medical Group and Sparrow Medical Group, and Clinical Assistant Professor at Michigan State University. Her expertise spans cognitive and behavioralassessments, chronic disease management, and interdisciplinary carecoordination. She has received several accolades, including the Futureof Long Term Medicine in Ohio Fellow Award.Dr. Vidholia is currently focused on developing a practice in Outpatient Geriatric Assessment as well as Geriatric primary care, where she creates personalized care plans that address the physical, mental, social, and emotional health needs of older adults. At the University of Michigan, she hopes to continue to apply her skills and passion for geriatric care.Outside of her professional life, Dr. Vidholia enjoys gardeningand cherishes her time with her family. Known affectionately as the ""4G' family"" because all their first names start with ""G,"" they love traveling across the U.S. and beyond.". Dr. Vidholia is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Vascular Dementia, Memory Loss, Cerebellar Degeneration, and Neuronal Intranuclear Inclusion Disease (NIID). Dr. Vidholia is board certified in Family Medicine and Geriatric Medicine.

Dr. Stoltz received her undergraduate and medical school degrees at the University of Michigan. Following her Internal Medicine residency, she completed fellowship training in Medical Oncology and Geriatric Medicine. She is board-certified in Geriatric Medicine and Hospice and Palliative Medicine. Dr. Stoltz has a clinical interest in palliative care/hospice care and is the Medical Director of Elara Caring Hospice in Brighton and Lansing, Michigan. Dr. Stoltz is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Dementia, Vitamin D Deficiency, and Osteoporosis.

Dr. Nwagwu received her medical degree from the University of Lagos-Nigeria, College of Medicine, 2004. She completed a Family Medicine residency at St. Mary Mercy Hospital, Livonia Michigan (part of Trinity Health System) in 2013, and a Geriatric Medicine fellowship at University of Michigan in 2014. She pursued an additional certification in wound care through the American Board of Wound Management in 2020. She is board certified in Family medicine, Geriatric medicine and Wound care.Her special interests include Geriatric primary care, Ambulatory clinics, Preventive medicine/ Wellness, Post-acute care ( subacute rehab care), Geriatric wound care/ wound care education , patient education as well as education for medical learners and trainees at various levels. Dr. Nwagwu is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Graves Disease, Thyroid Storm, Enlarged Prostate (BPH), and Type 2 Diabetes (T2D). Dr. Nwagwu is board certified in Family Medicine and Geriatric Medicine.